Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v3.20.2
Commitments and Contingencies (Details) - Planet Biotechnologies - USD ($)
3 Months Ended
Sep. 11, 2020
Sep. 30, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Collaborative Arrangement, One-Time Up-Front Payment $ 150,000  
Threshold period for one-time, non-refundable, milestone payments   30 days
Milestone payments due and payable in connection with any registration application   $ 0
Investigation New Drug Application    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   150,000
Fifth patient enrolled in a Phase I Trial of a Product    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   200,000
Fifth patient enrolled in a Phase II Trial of a Product    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   300,000
Fifth patient enrolled in a Phase III Trial of a Product    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   500,000
Approval of Biologics License Application    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   1,000,000
First Anniversary of Biologics License Application    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   1,000,000
Second Anniversary of Biologics License Application    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   1,000,000
Third Anniversary of Biologics License Application    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   1,000,000
Fourth Anniversary of Biologics License Application    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Milestone payments   $ 1,000,000